Literature DB >> 3013627

A single nucleotide difference at the 3' end of an intron causes differential splicing of two histocompatibility genes.

A L Archibald, N A Thompson, S Kvist.   

Abstract

The murine histocompatibility class I genes, H-2 Kb and Kk, display considerable homology at their 3' ends. In fact, from exon 5 to the termination codon, only two nucleotides differ between the two genes, one at the 5' end and the other at the 3' end of intron 7. Despite this similarity, the gene products have distinctly different mol. wts as determined by SDS-PAGE. By constructing two hybrid genes, pC2 and pC4, we demonstrated that it is the cytoplasmic parts of the antigens (encoded by exons 6-8) which are responsible for the major difference in mol. wt. We have used site-directed mutagenesis to change the two nucleotides in intron 7 of the H-2 Kk gene to those present in the H-2 Kb gene. S1 nuclease mapping has been used to identify the actual splice site of the authentic Kb and Kk genes, the hybrid genes and the mutagenized genes. We have shown that it is the 3' nucleotide difference, nine nucleotides upstream of the 3' splice site, which causes the different excision of intron 7 of the Kb gene. The 5' nucleotide difference does not alter the splicing. The choice of branch points and 3' splice signals for intron 7 of five H-2 class I genes, is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013627      PMCID: PMC1166888          DOI: 10.1002/j.1460-2075.1986.tb04309.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  60 in total

Review 1.  On the origin of RNA splicing and introns.

Authors:  P A Sharp
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

Review 2.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

3.  Stepwise assembly of a pre-mRNA splicing complex requires U-snRNPs and specific intron sequences.

Authors:  D Frendewey; W Keller
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

4.  An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens.

Authors:  H G Burgert; S Kvist
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

5.  Exonuclease III: use for DNA sequence analysis and in specific deletions of nucleotides.

Authors:  L H Guo; R Wu
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Role of the 3' splice site consensus sequence in mammalian pre-mRNA splicing.

Authors:  B Ruskin; M R Green
Journal:  Nature       Date:  1985 Oct 24-30       Impact factor: 49.962

7.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Ovalbumin gene: evidence for a leader sequence in mRNA and DNA sequences at the exon-intron boundaries.

Authors:  R Breathnach; C Benoist; K O'Hare; F Gannon; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Mouse histocompatibility genes: structure and organisation of a Kd gene.

Authors:  S Kvist; L Roberts; B Dobberstein
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  12 in total

1.  Structure and expression of a chicken MHC class I gene.

Authors:  G Kroemer; R Zoorob; C Auffray
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  Aberrant splicing events that are induced by proviral integration: implications for myb oncogene activation.

Authors:  D Rosson; D Dugan; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 3.  Multiple class I molecules generated from single genes by alternative splicing of pre-mRNAs.

Authors:  A M Lew; J McCluskey; W L Maloy; D H Margulies; J E Coligan
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

4.  Analysis of D2d: a D-region class I gene.

Authors:  M L Hedley; S W Hunt; K A Brorson; J S Andris; L Hood; J Forman; P W Tucker
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Signals controlling alternative splicing of major histocompatibility complex H-2 class I pre-mRNA.

Authors:  D E Handy; J McCluskey; A M Lew; J E Coligan; D H Margulies
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  A novel H-2K splice form: predictions for other alternative H-2 splicing events.

Authors:  J M Vogel; R Y Morse; R S Goodenow
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  Three new class I HLA alleles: structure of mRNAs and alternative mechanisms of processing.

Authors:  L Cianetti; U Testa; L Scotto; R La Valle; A Simeone; G Boccoli; G Giannella; C Peschle; E Boncinelli
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

8.  High-resolution one-dimensional isoelectric focusing of mouse MHC class I antigens. Identification of natural and experimentally induced class I antigens.

Authors:  H G Ljunggren; M Oudshoorn-Snoek; M G Masucci; H L Ploegh
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

9.  Direct selection for mutations affecting specific splice sites in a hamster dihydrofolate reductase minigene.

Authors:  I T Chen; L A Chasin
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

10.  Alternative processing of H-2Dd pre-mRNAs results in membrane expression of differentially phosphorylated protein products.

Authors:  J McCluskey; L F Boyd; W L Maloy; J E Coligan; D H Margulies
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.